SAT-373 PRIMARY MEMBRANOUS NEPHROPATHY MANAGEMENT WITH CALCINEURIN INHIBITORS AND ITS ASSOCIATED REMISSION AND LONG-TERM RELAPSE RATE: MEMBRANOUS G-COHORT STUDY

Majority of the studies on primary membranous nephropathy (PMN) based the relapse rate associated with calcineurin inhibitors (CNI) on relatively short-term follow-up (<2years). We look to identify the efficacy of calcineurin inhibitors in inducing and maintaining remission over long term follow-up of 2years or more.